1. Volume 142, Issue 2, Pages 231-236 (August 2016)
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 
M. Petrillo, G. Amadio, V. Salutari, I. Paris, M.G. Di Stefano, G. Ferandina, G. Scambia, A. Fagotti 
Gynecologic Oncology 
Volume 142, Issue 2, Pages (August 2016)
DOI: /j.ygyno
Copyright © 2016 Elsevier Inc. Terms and Conditions

2. Fig. 1 Flow-chart of our study population.
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2016 Elsevier Inc. Terms and Conditions

3. Fig. 2
Platinum-free interval in Cases (solid line) and Controls (dotted line).
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2016 Elsevier Inc. Terms and Conditions

4. Fig. 3
Time to Progression to second line chemotherapy in Cases (solid line) and Controls (dotted line).
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2016 Elsevier Inc. Terms and Conditions